SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

What is DAG? In more traditional blockchains, the host provides the food/drinks (i.e resources) for this party. And when the guests arrive, the amount of resources can only accommodate so many people, the portions are small and then everything eventually runs out and the party ends. Think Constellation DAG like a potluck (a party where everyone brings food/drinks). With every added guest (node to the network), the more resources the party has to keep going. This is the nature of Constellation, a distributed system that scales horizontally.  Is Constellation a Blockchain? Not exactly. Although inspired by the principles of decentralization, many standard blockchains such as Bitcoin and Ethereum face scalability issues. This is why the next, generation of decentralized networks such as Hashgraph, IOTA, and Constellation have turned to DAG.  What is a Microservice? “Microservices” is an approach to application development in which a large application is built as a suite of modular services. Each module supports a specific business goal and uses a simple, well-defined interface to communicate with other sets of services. Uber, for example, is not a singular app purse. It is a unified app which means it is a single interface that brings together their driver app, their rider app, and their corporate team app.

Constellation

Constellation (DAG) is trending as the community highlights its unique Layer 0 architecture and real-world utility in data infrastructure, particularly its active collaboration with the U.S. Department of Defense and recent acquisition by an AI-focused holding company. Investors are actively discussing the project's long-term enterprise potential, cross-chain integrations with Base, and the impact of its Tessellation v3.0 network upgrades on scalability.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

The MULN CRYPTO community is intensely polarized, with some members hyping the coin as a 'weekend runner' poised for massive gains, while a vocal contingent dismisses it as a 'scam' and 'rug pull' tied to the controversial history of its corporate namesake. Despite the persistent skepticism regarding its legitimacy, the community remains hyper-focused on social media trends, bot-driven volume, and speculative 'community takeover' narratives.

Pump.fun

Pump.fun is actively discussed within the Solana ecosystem as users debate the merits of its high-volume meme coin launchpad, contrasting the platform's viral success with community concerns over the prevalence of scams. Meanwhile, investors are closely monitoring related projects like $PMV and $WAGMI, with the community emphasizing the importance of long-term conviction and organic growth in navigating the volatility of microcap assets.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Wayne, PA.

Avalo Therapeutics Inc

Avalo Therapeutics is generating significant investor attention as the community closely monitors the development of its lead hidradenitis suppurativa candidate, AVTX-009, with upcoming Phase 2 data acting as a key catalyst. Discussions are heavily focused on the stock's high volatility and massive volume spikes, with participants debating its long-term potential versus concerns regarding ongoing funding needs and clinical execution risks.

ProShares Trust - ProShares UltraPro Short QQQ -3x Shares

ProShares UltraPro Short QQQ

ProShares UltraPro Short QQQ (SQQQ) is seeing heightened activity as market participants navigate extreme volatility fueled by rising geopolitical tensions in the Middle East and concerns over the sustainability of the AI-driven data center boom. Investors remain deeply divided, with many actively debating whether to use the symbol as a hedging tool against a potential broader market correction or to exploit its structural decay by selling into rallies.

Shido

Shido is generating significant buzz as it transitions into an optimized execution network, highlighted by the recent launch of BubblePAD and BubbleDNA to enhance its ecosystem utility. Community members are actively discussing the project's long-term technical roadmap, including its move to Nova EVM infrastructure and ongoing efforts to drive network security through high staking participation.

Molina Healthcare, Inc. engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.

Molina Healthcare Inc

Molina Healthcare (MOH) is experiencing extreme volatility and intense community focus following a significant earnings miss, a downward revision in full-year guidance, and concerns regarding rising medical costs. Investors are debating whether the current sell-off presents a generational buying opportunity or if structural risks, including potential shifts in ACA subsidies and sector-wide regulatory pressures, warrant a more cautious, wait-and-see approach.

Maul Coin

Maul Coin is trending as the community rallies behind an active developer and promotes its roadmap to build long-term value despite the lack of a formal chart. Investors are actively discussing the potential for a parabolic breakout and pushing for broader exposure on social platforms to reach new market capitalization milestones.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

Energy Select Sector SPDR Fund (XLE) is trending as investors grapple with extreme volatility driven by escalating geopolitical tensions in the Middle East and concerns over potential supply chain disruptions in the Strait of Hormuz. The community remains focused on the impact of conflict on global energy flows, with active debates centered on whether current price premiums are sustainable or if the sector faces a significant correction due to broader recessionary risks.

Hedera is a decentralized public network where developers can build secure, fair applications with near real-time consensus. The platform is owned and governed by a council of global innovators including Avery Dennison, Boeing, Deutsche Telekom, DLA Piper, FIS (WorldPay), Google, IBM, LG Electronics, Magalu, Nomura, Swirlds, Tata Communications, University College London (UCL), Wipro, and Zain Group.   The Hedera Consensus Service (HCS) acts as a trust layer for any application or permissioned network and allows for the creation of an immutable and verifiable log of messages. Application messages are submitted to the Hedera network for consensus, given a trusted timestamp, and fairly ordered. Use HCS to track assets across a supply chain, create auditable logs of events in an advertising platform, or even use it as a decentralized ordering service.

Hedera Hashgraph

Hedera Hashgraph is currently being monitored by the community as investors debate its long-term enterprise utility versus recent price underperformance and inflationary concerns. While some traders are expressing frustration over stagnant price action, others are actively accumulating the token, viewing current levels as a strategic entry point ahead of expected regulatory clarity and institutional adoption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A Key "Master" Protein That Declines by Half After Age 40. One Company Found a Way to Restore It.

A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. A Key 'Master' Protein That Declines by Half After Age 40. One Company Found a Way to Restore It. PR...

Longeveron (LGVN) Q4 2025 Earnings Call Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Longeveron Braces For Q4 Results Following Recent Funding Boost

Longeveron Inc. shares are trading higher Tuesday as investors pivot their focus toward the company's Q4 earnings report, due after the bell.read more...

Longeveron (LGVN) Shares Surge On $30 Million Private Placement Deal

Longeveron shares are trading sharply higher Tuesday afternoon following the announcement of a private placement agreement worth up to $30 million.read more...

Best Biotech Stocks To Keep An Eye On - March 10th

Vertex Pharmaceuticals, BioNTech, Danaher, Longeveron, Moderna, United Therapeutics, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech...

<ul class="summary-bullets"><li>The company said that laromestorcel infusions resulted in clinically meaningful, dose-and time-dependent increases in the primary endpoint of the 6-minute walk test compared with placebo.</li><li>The company was evaluating whether its investigational therapy improves physical functioning in 148 ambulatory individuals with frailty.</li><li>The therapy is currently being evaluated in multiple indications including hypoplastic left heart syndrome (HLHS) and Alzheimer’s disease (AD).</li></ul>Shares of Longeveron Inc. (LGVN) rose 7% on Wednesday, before paring back gains, after the company announced positive results from the trial of its investigational therapy in age-related clinical frailty.The company said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo, in a study.LGVN shares traded 9% lower at the time of writing.<h2 class="st-heading-2">Trial Outcomes</h2>The company said that laromestorcel infusions resulted in clinically meaningful, dose-and time-dependent increases in the primary endpoint of the 6-minute walk test compared with placebo. The 6-Minute Walk Test (6MWT) is a submaximal, standardized exercise test measuring the distance a patient can walk on a flat, hard surface in six minutes.“We are highly encouraged by these Phase 2b results that demonstrate the potential of stem cell therapy to improve the condition of patients with aging-related frailty,” <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://investors.longeveron.com/news/News/news-details/2026/Longeveron-Results-of-Phase-2b-Clinical-Trial-Demonstrating-Stem-Cell-Therapy-Improved-Condition-of-Patients-with-Age-Related-Frailty-Published-in-Cell-Stem-Cell/default.aspx">said</a> Joshua M. Hare, Chief Science Officer at Longeveron. “Those with Aging Frailty are disproportionately compromised in their ability to cope with every day and acute stressors, are at high vulnerability to disease and injury, and are at increased risk for poor outcomes and death after surgery.”Laromestrocel, the company’s lead investigational product, is a human bone marrow-derived allogeneic stem cell (MSC) investigational therapy. The company was evaluating whether it improves physical functioning in 148 ambulatory individuals with frailty. The therapy is currently being evaluated in multiple indications including hypoplastic left heart syndrome (HLHS), Alzheimer’s disease (AD), and Pediatric Dilated Cardiomyopathy (DCM).<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around LGVN stock rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume rose from ‘normal’ to ‘high’ levels.A Stocktwits user said that positive news from the company never helps the stock price.<stembedurl>https://www.stocktwits.com/Dorps332/message/645856800</stembedurl><a href="https://stocktwits.com/symbol/LGVN">LGVN stock</a> is down by 64% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-odd-shares-tumble-today/cZRyBHbRIGS">Why Did ODD Shares Tumble More Than 50% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Longeveron, Inc. logo appears on a smartphone screen in this illustration photo in Reno, United States, on January 3, 2025. (Photo Illustration by Jaque Silva/NurPhoto via Getty Images)

LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study

Longeveron said that intravenous laromestrocel improved the physical condition of patients with age-related clinical frailty after nine months, compared to placebo.

Equity

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

Longeveron Inc - Ordinary Shares - Class A

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$1.07
Prev Close	$1.12
Open	$1.11
Dividend Yield	0.00%
50-Day Moving Average	$0.698
Beta	1.02
Avg. Volume	14.62M
PE Ratio	-0.82

52-Week High	$1.83
52-Week Low	$0.475
Market Capitalization	$24.9M
EPS (Annual)	-$1.29
Price to Book	4.32
Revenue Per Employee	$31,552.63

LGVN
Longeveron Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LGVN News

LGVNLongeveron Inc - Ordinary Shares - Class A